Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Caliway Biopharmaceuticals (6919.TW) Q2 2025 Earnings
6919.TW
5
May
Confirmed
Q4 2024
Q1 2025
Q2 2025
-1.36
-0.94
-0.52
-0.1
Details
Expected EPS
-0.12883564512
Actual EPS
-0.09991335744
Surprise EPS
0.03
Surprise Percent
+22.45%
Description
Caliway Biopharmaceuticals (6919.TW) has reported earnings of -0.09991335744 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login